It's very easy to move a stock one way or the other especially in a high-octane, low-float, thinly traded and highly debated stock/drug like ONTY/Stimuvax. The company has less than 45 million outstanding and I would be willing to bet that after the last financing and the way the stock has moved after the last financing (if you are to believe Kirkman when he said other large institutional investors were waiting on the sidelines until we raised more capital), the tradeable stock is very little. We'll will find out mid-August who those investors were - it wouldn't surprise me to see an FMR-type or another large asset manager as having taken a 5-10% investment in the company - simply by observing the way the stock moved from $4 to $9.00. ARIA traded very similar when FMR was accumulating their 15% stake in the name.
SeekingAlpha is a pretty painful space. It used to be really legit, and now anyone can essentially post what they want, whether its bullish or bearish. The stock moved a couple points on a bullish note last week, down on a bearish note today. This will all mean zero when the results come out...it's just noise.
One thing I think I know for sure: it's either going to 30.00, or it's going to 3.00.
Market Data 
Markets 
AI
